Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Neuro-Oncology(2020)10.1093/neuonc/noaa168Source: DataRank Database

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design is a research paper published in Neuro-Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 116 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access116 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 6.94)OA: hybridTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Karla V. Ballman ORCID,Martin J. van den Bent ORCID,Caterina Giannini ORCID,Evanthia Galanis ORCID,Paul D. Brown ORCID

Live enrichment

PubMed:32678879 PMC:PMC7992874 OpenAlex:https://openalex.org/W3043701315

National Institutes of Health

Grant: U10CA180821

National Institutes of Health

Grant: U10CA180882